Form D · Other Technology

CytoViva Inc

Auburn, AL · CIK 0001386591

Offering snapshot reported Nov 6, 2023 · SEC filing

Reported sold
$50K
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 25, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 6, 2023Initial$50,000No comparison1SEC filing
Jun 16, 2011Initial$50,000No comparison1SEC filing
Apr 29, 2009Initial$685,000No comparisonNot reportedSEC filing
Jan 3, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-496541

Source: Form D, filed Nov 6, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Cary S Chandler Director
Byron J Cheatham Director, Executive
Lawrence W. Greer Director
Thomas R Lawrence Director, Executive
John O. Lawrence Director, Executive
Samuel M. Lawrence Director, Executive
Charles T Ludwig Director, Executive
C Mixchael Moriarty Director
Lloyd Nix Director
Charles C Pinckney Director
Gordon M Sherman Director
Benjamin H Thompson Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
300 North Dean Rd Suite 5 Pmb 157
Auburn, AL, 36830